Recursion Pharmaceuticals Inc - Ordinary Shares - Class A

NASDAQ:RXRX   3:59:51 PM EDT
18.31
-0.14 (-0.76%)
Products

Recursion Is Granted FDA Fast Track Designation For Rec-2282 For The Potential Treatment Of Nf2-Mutated Meningiomas

Published: 10/07/2021 12:31 GMT
Recursion Pharmaceuticals Inc - Ordinary Shares - Class A (RXRX) - Recursion is Granted FDA Fast Track Designation for Rec-2282 for the Potential Treatment of Nf2-mutated Meningiomas.